- Home
- CSAN vs IRON Comparison
CSAN vs IRON Comparison
Compare CSAN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAN
- IRON
- Stock Information
- Founded
- CSAN 1936
- IRON 2017
- Country
- CSAN Brazil
- IRON United States
- Employees
- CSAN N/A
- IRON N/A
- Industry
- CSAN Retail-Auto Dealers and Gas Stations
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- CSAN Consumer Discretionary
- IRON Health Care
- Exchange
- CSAN Nasdaq
- IRON Nasdaq
- Market Cap
- CSAN 2.3B
- IRON 1.9B
- IPO Year
- CSAN N/A
- IRON N/A
- Fundamental
- Price
- CSAN $5.13
- IRON $54.53
- Analyst Decision
- CSAN Strong Buy
- IRON Strong Buy
- Analyst Count
- CSAN 1
- IRON 10
- Target Price
- CSAN $19.00
- IRON $74.40
- AVG Volume (30 Days)
- CSAN 1.2M
- IRON 336.7K
- Earning Date
- CSAN 02-26-2025
- IRON 03-20-2025
- Dividend Yield
- CSAN 6.75%
- IRON N/A
- EPS Growth
- CSAN N/A
- IRON N/A
- EPS
- CSAN 0.22
- IRON N/A
- Revenue
- CSAN $7,655,547,290.00
- IRON N/A
- Revenue This Year
- CSAN $330.06
- IRON N/A
- Revenue Next Year
- CSAN $2.09
- IRON N/A
- P/E Ratio
- CSAN $5.80
- IRON N/A
- Revenue Growth
- CSAN 3.43
- IRON N/A
- 52 Week Low
- CSAN $4.95
- IRON $25.60
- 52 Week High
- CSAN $14.81
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- CSAN 44.38
- IRON 41.25
- Support Level
- CSAN $5.24
- IRON $52.21
- Resistance Level
- CSAN $5.64
- IRON $55.89
- Average True Range (ATR)
- CSAN 0.17
- IRON 1.86
- MACD
- CSAN 0.02
- IRON 0.20
- Stochastic Oscillator
- CSAN 26.28
- IRON 48.48
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.